Last info update: April 2023
Kevin noffsinger email & phone,  at Alexion pharmaceuticals, inc.

Kevin Noffsinger — Contact Information

Kevin Noffsinger's Email, Phone & Whatsapp Number and other Contact Information

  • Emails Email d***com
    Open contact Available for registered users
  • Phones Phone +***067
    +***364
    Open contact Available for registered users
  • Location Location Aurora, Colorado, United States
  • Skills Skills Detoxification · Nutrition · Health · Wellness · Healing · Chiropractic · Healthcare · Rehabilitation · Pediatrics · Fitness · Lifestyle · Pain Management · Stress · Health Education · Myofascial Release · Headaches · Spine · Holistic Health · Neck Pain · Pregnancy · Sciatica · Sports Medicine · Leadership · Shoulder Pain · Sports Injuries · Treatment · Low Back Pain · Chronic Pain · Acupuncture · Fitness Training · Musculoskeletal · Wellbeing · Exercise Physiology · Nutritional Counseling · Chronic Illness · Alternative Medicine · Corporations · Supplements · Physical Therapy · Clin

Kevin Noffsinger. Works at Alexion Pharmaceuticals, Inc.(United States). Located in Aurora, Colorado, United States. Open Kevin Noffsinger's email & phone: D***com, +***067. Skilled in Detoxification · Nutrition · Health · Wellness · Healing · Chiropractic · Healthcare · Rehabilitation · Pediatrics · Fitness · Lifestyle · Pain Management · Stress · Health Education · Myofascial Release · Headaches · Spine · Holistic Health · Neck Pain · Pregnancy · Sciatica · Sports Medicine · Leadership · Shoulder Pain · Sports Injuries · Treatment · Low Back Pain · Chronic Pain · Acupuncture · Fitness Training · Musculoskeletal · Wellbeing · Exercise Physiology · Nutritional Counseling · Chronic Illness · Alternative Medicine · Corporations · Supplements · Physical Therapy · Clin.

Kevin noffsinger's Company Details

Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hemat Read more ologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). In April 2009 and August 2009, the United States food and drug administration (FDA) and the European Commission (E.C.), respectively, granted Soliris orphan drug designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island manufacturing facility received regulatory approval from the E.C. Or the production of Soliris.

  • Company Emails [email protected]
  • Company Phone (203) 272-2596
  • Company Website alexion.com
  • Company Location boston, massachusetts, united states
  • Industry biotechnology
  • Company Size 1001-5000
  • Found Year 1992
Click to load map
Colleagues
Similar employees

Frequently Asked Questions

Directories